rs1060499690
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_032520.5(GNPTG):c.324G>A(p.Trp108*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_032520.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
GNPTG-mucolipidosis Pathogenic:1
- -
Mucolipidosis Pathogenic:1
The p.Trp108X variant in GNPTG has not been previously reported in the literatur e and was absent from large population studies, but has been reported in ClinVar (Variation ID #397575). This nonsense variant leads to a premature termination codon at position 108 which is predicted to lead to a truncated or absent protei n. Loss of function is a reported mechanism of disease for this gene. In summary , although additional studies are required to fully establish its clinical signi ficance, the p.Trp108X variant is likely pathogenic for Mucolipidosis III gamma based on predicted impact on protein and absence from the general population. AC MG/AMP Criteria applied: PM2, PVS1 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at